Bain research shows that some medtech companies are more likely to outperform their peers during and after the Covid-19 crisis. These winning firms are category leaders. With hospitals seeking to ensure quality, consistency of supply and a long-term partnership as they reduce the number of vendors they use, leaders in each individual category are likely to win market share. At this point in time, it’s imperative for medtech management teams to understand category leadership and employ it as a powerful tool for portfolio strategy and M&A choices.
Read the full article: Why Category Leadership Matters More Than Ever in Medtech //
Source: https://www.bain.com/insights/why-category-leadership-matters-more-than-ever-in-medtech